Response Biomedical Corp. (RPBIF)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SERVICES-TESTING LABORATORIES
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

1781 - 75TH AVENUE W. VANCOUVER, BRITISH COLUMBIA, CANADA V6P6P2

Response Biomedical Corp. engaged in the research, development and commercialization of diagnostic technologies for the medical point of care (POC) and on-site environmental testing markets. The Company develops, manufactures and sells diagnostic tests for use with its RAMP System, a fluorescent immunoassay-based on-site diagnostic testing platform. The RAMP technology utilizes a method to account for sources of error inherent in lateral flow immunoassay technologies, thereby providing the ability to detect and quantify an analyte present in a liquid sample. As of December 31, 2005, the Company had nine RAMP tests available for environmental and clinical testing applications and the Company has plans to commercialize additional tests. RAMP tests are commercially available for use in the early detection of heart attack, environmental detection of West Nile virus, and biodefence applications including the rapid on-site detection of anthrax, smallpox, ricin and botulinum toxin.

View SEC Filings from RPBIF instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RPBIF (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RPBIF BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WANG JONATHAN JIAN

  • Director
  • 10% Owner
0 2016-11-29 0

SEVERSON CLINTON

  • Director
No longer subject to file 2016-11-29 0

KEEGAN JOSEPH D

  • Director
No longer subject to file 2016-11-29 0

SHUSTER LEWIS

  • Director
No longer subject to file 2016-11-29 0

THOMPSON PETER A.

  • Director
  • 10% Owner
0 2016-11-29 0

HOLLER ANTHONY F

  • Director
No longer subject to file 2016-11-29 0

KINNAIRD-STEEN BARBARA CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2016-11-29 0

ADAMS WILLIAM J. CFO & CORPORATE SECRETARY

  • Officer
No longer subject to file 2016-11-29 0

ORBIMED ADVISORS LLC

ORBIMED ADVISORS LTD

ISALY SAMUEL D

ORBIMED ASIA GP, LP

ORBIMED CAPITAL GP III LLC

  • Director
  • 10% Owner
0 2016-11-29 0

WANG DAVID

  • Director
No longer subject to file 2015-05-19 0

HANGZHOU LIZHU MEDICAL INSTRUMENT & REAGENT CO. LTD.

FU LIMING

ZHOU XUYI

XU WENJIE

  • 10% Owner
900,000 2014-12-12 0

HANGZHOU JOINSTAR MEDICAL INSTRUMENT & REAGENT CO. LTD.

FU LIMING

ZHOU XUYI

XU WENJIE

  • 10% Owner
900,000 2014-12-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments